Your browser doesn't support javascript.
loading
Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.
Mateos, Maria V; Gavriatopoulou, Maria; Facon, Thierry; Auner, Holger W; Leleu, Xavier; Hájek, Roman; Dimopoulos, Meletios A; Delimpasi, Sosana; Simonova, Maryana; Spicka, Ivan; Pour, Ludek; Kriachok, Iryna; Pylypenko, Halyna; Doronin, Vadim; Usenko, Ganna; Benjamin, Reuben; Dolai, Tuphan K; Sinha, Dinesh K; Venner, Christopher P; Garg, Mamta; Stevens, Don A; Quach, Hang; Jagannath, Sundar; Moreau, Philippe; Levy, Moshe; Badros, Ashraf Z; Anderson, Larry D; Bahlis, Nizar J; Cavo, Michele; Chai, Yi; Jeha, Jacqueline; Arazy, Melina; Shah, Jatin; Shacham, Sharon; Kauffman, Michael G; Richardson, Paul G; Grosicki, Sebastian.
Afiliação
  • Mateos MV; Hospital Universitario de Salamanca, Salamanca, Spain. mvmateos@usal.es.
  • Gavriatopoulou M; Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Facon T; CHU Lille Service Des Maladies du Sang, 59000, Lille, France.
  • Auner HW; Imperial College London, London, UK.
  • Leleu X; Department of Hematology, CHU La Miletrie and Inserm CIC 1402, Poitiers, France.
  • Hájek R; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece.
  • Delimpasi S; General Hospital Evangelismos, Athens, Greece.
  • Simonova M; Institute of Blood Pathology and Transfusion Medicine of NAMS of Ukraine, Lviv, Ukraine.
  • Spicka I; Charles University and General Hospital, Prague, Czech Republic.
  • Pour L; University Hospital Brno, Brno, Czech Republic.
  • Kriachok I; National Cancer Institute, Kiev, Ukraine.
  • Pylypenko H; Cherkassy Regional Oncological Center, Cherkassy, Ukraine.
  • Doronin V; City Clinical Hospital #40, Moscow, Russian Federation.
  • Usenko G; City Clinical Hospital No. 4 of Dnipro City Council, Dnipro, Ukraine.
  • Benjamin R; Kings College Hospital NHS Foundation Trust, London, UK.
  • Dolai TK; Nil Ratan Sircar Medical College and Hospital, Kolkata, India.
  • Sinha DK; State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India.
  • Venner CP; Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
  • Garg M; University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Stevens DA; Norton Cancer Institute, St. Matthews Campus, Louisville, KY, USA.
  • Quach H; St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia.
  • Jagannath S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Moreau P; Hotel-Dieu, University Hospital, Nantes, France.
  • Levy M; Baylor University Medical Center, Dallas, TX, USA.
  • Badros AZ; Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.
  • Anderson LD; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.
  • Bahlis NJ; Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, USA.
  • Cavo M; Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.
  • Chai Y; Karyopharm Therapeutics Inc, Newton, MA, USA.
  • Jeha J; Karyopharm Therapeutics Inc, Newton, MA, USA.
  • Arazy M; Karyopharm Therapeutics Inc, Newton, MA, USA.
  • Shah J; Karyopharm Therapeutics Inc, Newton, MA, USA.
  • Shacham S; Karyopharm Therapeutics Inc, Newton, MA, USA.
  • Kauffman MG; Karyopharm Therapeutics Inc, Newton, MA, USA.
  • Richardson PG; Dana Farber Cancer Institute, Boston, MA, USA.
  • Grosicki S; Medical University of Silesia, Katowice, Poland.
J Hematol Oncol ; 14(1): 59, 2021 04 13.
Article em En | MEDLINE | ID: mdl-33849608
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triazóis / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Bortezomib / Hidrazinas / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triazóis / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Bortezomib / Hidrazinas / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido